Clinitech Laboratory Peer Comparison

BSE: 544220

₹35.10

₹-1.50 (-4.10%)

As on 01-Sep-2026IST

Market cap

₹8 Cr

Revenue (TTM)

₹8 Cr

P/E Ratio

19.2

P/B Ratio

--

Div. Yield

0 %

Edit

	Clinitech Laboratory	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Market cap (₹ Cr)	8	39,996	33,199	32,077	15,603
Revenue (₹ Cr)	8	4,683	4,213	2,891	857
Net Profit (₹ Cr)	0.39	552.34	190.80	546.30	187.49
Net Margin (%)	4.66	11.55	4.49	18.23	21.32
RoE (%)	6.38	14.93	9.45	23.03	20.58
Price to Earnings	19.17	71.91	162.50	59.19	83.22
Price-To-Book	--	9.73	8.77	12.28	15.49

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Clinitech Laboratory	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Operating Revenue	8.23	3,692.35	3,035.10	2,461.40	681.39
Total Income	8.46	3,797.15	3,067.00	2,554.83	699.71
Total Expenditure	7.40	2,831.90	2,242.10	1,765.80	408.17
EBITDA	0.83	860.44	793.00	695.60	273.22
Depreciation	0.45	193.75	177.20	141.92	70.60
EBIT	0.38	666.69	615.80	553.67	202.62
Interest	0.06	74.35	100.40	22.31	26.74
Other Income	0.23	104.81	31.90	93.43	18.32
Exceptional Items	--	-49.90	10.80	--	-1.03
Profit before Tax	0.55	647.26	558.10	624.80	193.16
Provision for Tax	0.16	165.94	143.30	132.55	49.37
Profit after Tax	0.39	481.32	414.80	492.25	143.79

Liabilities (₹ Cr)

	Clinitech Laboratory	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Shareholder's Funds	8.83	3,386.41	2,137.80	2,172.72	799.14
Minority Interest	--	1.10	281.00	33.76	--
Non-Current Liabilities	0.03	726.88	2,421.10	21.34	311.86
Current Liabilities	1.68	618.82	836.20	402.35	162.61
Total Liabilities	10.71	4,766.23	5,689.20	2,713.41	1,273.62

Assets (₹ Cr)

	Clinitech Laboratory	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Non-Current Assets	3.21	3,200.08	4,978.80	1,266.66	966.41
Current Assets	7.34	1,533.12	697.30	1,363.51	307.21
Total Assets	10.71	4,766.23	5,689.20	2,713.41	1,273.62
Total Debt*	0.00	327.88	1,910.90	0.00	0.00
Net Current Assets	5.66	914.31	-138.90	961.16	144.59
Contingent Liabilities	--	88.77	83.80	10.59	0.13

Cashflow (₹ Cr)

	Clinitech Laboratory	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Cash From Operating Activities	-0.88	623.76	581.80	568.89	224.47
Cash Flow from Investing Activities	-0.73	-720.94	-1,116.20	-303.16	-181.88
Cash from Financing Activities	3.98	-97.23	543.10	-334.03	-52.05
Net Cash Inflow / Outflow	2.37	-194.41	8.70	-68.31	-9.45

Ratios

Profitability Ratios

	Clinitech Laboratory	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
ROCE (%)	9.21	20.50	19.02	31.53	30.20
ROE (%)	6.38	15.31	20.92	25.15	19.99
ROA (%)	4.94	10.72	8.74	19.53	12.76
EBIT Margin (%)	12.87	26.14	27.18	32.06	42.79
Net Margin (%)	4.66	12.68	13.52	19.27	20.55
Cash Profit Margin (%)	10.26	18.28	19.51	25.76	31.46

Growth Ratios

	Clinitech Laboratory	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Revenue Growth (%)	28.61	12.74	21.49	10.54	24.39
EBIT Growth (%)	2.21	9.24	24.83	16.31	20.61
Net Profit Growth (%)	6.33	0.68	23.49	35.87	20.19
EPS Growth (%)	-21.73	0.65	24.03	35.99	20.67
Book Value Growth (%)	148.87	16.71	16.93	17.68	19.36

Valuation Ratios

	Clinitech Laboratory	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Price / Earnings	23.27	66.85	66.51	21.26	71.86
Price / Book Value	1.04	9.50	11.96	9.79	13.20
Dividend Yield (%)	0.00	0.04	0.00	0.97	0.20
EV/EBITDA	5.77	32.52	33.22	25.19	35.28
Market Cap (₹ Cr)	9.18	32,181.74	25,571.93	20,714.85	10,333.01

Solvency Ratios

	Clinitech Laboratory	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Debt to Equity	0.00	0.10	0.89	0.00	0.00
Short term debt to equity ratio	--	--	0.06	--	--
Current Ratio	4.36	2.48	0.83	3.39	1.89
Quick Ratio	4.05	2.37	0.76	3.30	1.86
Interest Coverage	11.07	9.71	6.56	29.01	8.22

Operating Efficiency Ratios

	Clinitech Laboratory	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Debtors to sales (%)	18.72	7.90	13.03	3.58	2.17
Asset Turnover	1.03	0.82	0.64	0.98	0.60
Receivable days	47.42	25.07	41.48	12.27	8.30
Inventory Days	18.01	6.62	6.82	5.45	2.71
Payable days	113.97	79.17	135.60	134.04	142.28
Cash Conversion Cycle	-48.54	-47.48	-87.31	-116.32	-131.27

Annual
Quarterly